Vigabatrin and alterations of the visual field;Vigabatrina y alteracion del campo visual

Revista de Neurologia

Volumn 28, Issue 8, 1999, Pages 741-745

  Argumosa, A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Children; Vigabatrin; Visual fields

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LOSIGAMONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; DRUG DERIVATIVE;

ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; EPILEPSY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MEDICAL LITERATURE; OPHTHALMOSCOPY; PATHOPHYSIOLOGY; PATIENT MONITORING; PERIMETRY; REMISSION; TREATMENT OUTCOME; VISUAL FIELD DEFECT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOCAL EPILEPSY; RETROSPECTIVE STUDY; REVIEW; VISUAL FIELD;

ADOLESCENT; ANTICONVULSANTS; CHILD; DOUBLE-BLIND METHOD; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; RECEPTORS, GABA; RETROSPECTIVE STUDIES; VIGABATRIN; VISUAL FIELDS;

EID: 0032954885     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2808.99015     Document Type: Article

References (5)

1. Grant SM, Heel RC. Vigabatrin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 1991; 41: 916-9.
2. Butler WH. The neuropathology of vigabatrin. Epilepsia 1989; 30 (Suppl 3): S15-7.
3. Fisher RS, Kerrigan JF. Vigabatrin: toxicity. In Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4 ed. New York: Raven Press; 1995. p. 931-9.
4. French J, Mosier M, Walker S, Somerville K, Sussman N. A double-blind placebo controlled study of vigabatrin 3.2 g/day in patients with uncontrolled complex partial seizures. Neurology 1996; 46: 54-61.
5. Cocito L, Maffini M, Loeb C. MRI findings in epileptics patients on vigabatrin for more than five years. Seizure 1992; 1: 163-5.